Anthropic Acquires Biotech Startup Coefficient Bio for $400M
Anthropic, a prominent AI company, has acquired biotech startup Coefficient Bio in a $400 million stock deal. The acquisition underscores Anthropic’s strategy to expand its AI capabilities into biotechnology, a field increasingly shaping healthcare and pharmaceutical industries.
Coefficient Bio, which operated in stealth until now, specializes in leveraging AI for genomic analysis and drug discovery. By integrating Coefficient Bio’s expertise, Anthropic is poised to explore breakthroughs in precision medicine and biological research. The deal also highlights increasing interest in AI’s role in biotech, where companies aim to shorten development timelines and reduce costs for drug trials.
This acquisition marks Anthropic’s broader ambition to diversify and strengthen its AI applications beyond textual and conversational models, aligning with a competitive market where leading players like OpenAI and Google are pursuing similar multidisciplinary ventures.